The Cooper Companies, Inc. (COO) fair value analysis
S&P 500 & Nasdaq · Updated 2026-09-07
The Cooper Companies, Inc. manufactures and markets contact lenses, intraocular lenses, and associated products used in vision correction and eye care. The company operates globally, serving customers across North America, Europe, Asia Pacific, and other international markets.
Forward Fair Value verdict
UndervaluedBased on TickrTrends' weekly Forward Fair Value model, COO is trading at more than a 25% discount to estimated fair value.
COO currently ranks #16 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.
- Last price
- $69.59
- Sector
- Healthcare
- 12-month range
- $60.19–$83.92
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- A
- Momentum grade
- A
- Leverage
- Low
- Margin trend
- Stable
- Revenue growth
- Modest
- RSI zone
- Neutral
- 50/200-day trend
- Downtrend
- 52-week position
- The lower-middle quarter of its range
- DCF cross-check
- Overvalued
What our data shows for COO
- Our model validated 17 trailing price-to-earnings windows for COO, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $60.19–$83.92.
- The 14-day relative strength index sits at a neutral 36.
- 4 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for COO
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent COO news
TickrTrends' derived news-sentiment signal for COO is currently leaning positive, computed from recent coverage.
- The Cooper Companies Inc (COO) Stock Down 3.6% -- Now Undervalued? GF Score: 89/100 (gurufocus.com, 2026-08-25)
TickrTrends take: The Cooper Companies operates in the Healthcare sector and has received a GF Score of 89 out of 100, suggesting strong fundamental quality metrics. TickrTrends currently derives an Undervalued verdict for COO, and the recent stock decline presents a valuation-focused reader with an opportunity to monitor whether the market's repricing aligns with the company's underlying business fundamentals. Investors tracking valuation metrics should observe whether COO maintains its favorable quality assessment as the stock adjusts to recent trading activity. - Pullback Created an Attractive Entry Point in The Cooper Companies (COO) (finance.yahoo.com, 2026-07-15)
TickrTrends take: The Cooper Companies operates in the Healthcare sector and is currently assessed as Undervalued according to TickrTrends valuation analysis. A pullback in the stock price creates potential opportunity for investors focused on valuation metrics, particularly if the fundamental business performance remains intact. Valuation-focused readers should monitor whether Cooper Companies' operational metrics and earnings trajectory support the current undervaluation assessment, as these factors will determine whether the pullback represents a sustained repricing or a temporary market dislocation.
What people are saying
Follow the COO conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is COO stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), COO is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is COO's TickrTrends verdict?
COO's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does COO compare to other Healthcare stocks?
COO ranks #16 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.
Is COO overbought or oversold?
COO's 14-day RSI is in neutral territory - neither overbought nor oversold.
More in Healthcare
Head-to-head comparisons
COO vs AMPH · COO vs ANIP · COO vs DXCM · COO vs HALO · COO vs ISRG